Zotiraciclib
Zotiraciclib Uses, Dosage, Side Effects, Food Interaction and all others data.
Zotiraciclib is under investigation in clinical trial NCT02942264 (Zotiraciclib (TG02) Plus Dose-dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma).
| Trade Name | Zotiraciclib |
| Generic | Zotiraciclib |
| Type | |
| Formula | C23H24N4O |
| Weight | Average: 372.472 Monoisotopic: 372.195011409 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Zotiraciclib
